Single and Multiple Ascending Dose, First-in- Human Study in Healthy Subjects

NCT04044339 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: TD-5202
DRUG: Placebo

Sponsor

Theravance Biopharma